Stille AB (publ) today presents the report for the third quarter 2025.

MAR

Revenue amounted to 138.8 MSEK (127.9), an increase of 8.5 percent, of which a negative organic growth of 1.9 percent. The quarter was negatively impacted by the phase-out of non-strategic products in surgical instruments that began in early 2025 and a negative currency effect. Adjusted for these two factors, underlying organic growth would have amounted to 7.3 percent.

We had a continued strong demand and acquisition-driven sales growth in a quarter characterized by negative currency effects and stabilization of the supply chain” says Ulrik Berthelsen. “Looking ahead to 2026, we anticipate a return to growth driven by a combination of strong order intake, operational improvements and commercial execution.

The gross profit margin in the quarter amounted to 48.8 percent (53.1) and EBIT before non-recurring items amounted to 17.3 MSEK (24.4).

MSEKJUL–SEP
2025
JUL–SEP
2024
JAN–SEP 2025JAN–SEP 2024OCT–SEP 2024/2025JAN–DEC 2024
Net sales138.8127.9392.7408.7554.0569.9
Gross profit, %48.853.150.649.352.151.9
EBITDA before non-recurring items26.131.375.796.2122.0142.4
EBITDA before non-recurring items, %18.824.519.323.522.025.0
EBITDA19.031.368.676.190.598.0
EBITDA, %13.724.517.518.616.317.2
EBIT before non-recurring items17.324.451.875.791.0114.9
EBIT before non-recurring items, %12.519.113.218.516.420.2
EBIT10.324.444.755.759.570.5
EBIT, %7.419.111.413.610.712.4
Datum 2025-10-23, kl 08:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!